Risk vs. Benefit Lessons from the ORAL Surveillance Study
Jan 27, 2022
Latest ACR News
In an editorial in the current edition of the NEJM, Dr. Jasvinder Singh comments on the Oral Surveillance trial (Ytterberg et al.), a 4-year randomized, open-label, noninferiority, postauthorization, safety end-point trial, in high risk active rheumatoid arthritis patients over age 50 years.Read Article
Laura Cappelli cappelliMD
2 years 2 months ago
Hope to have many more interdisciplinary discussions re. irAEs #ACR19 @LCalabreseDO @CCalabreseDO @EladSharonMD @DrJNaidoo @UmaThanaMD @lexmeara @drdavidliew https://t.co/8KDorKW2WJ
Janet Pope Janetbirdope
2 years 2 months ago
Great ACR 2019. We weathered the weather #ACR @RheumNow https://t.co/lCKxADudRf
Philip Robinson philipcrobinson
2 years 2 months ago
Different centres have different yields from temporal artery biopsy independent of biopsy length #ACR19 @RheumNow Abs 2685 https://t.co/Gqy9sY4OrM
Angelo Gaffo ALGaffoRheumMD
2 years 2 months ago
Just took few pictures during social media gathering yesterday at #ACR19. It was so nice to meet everyone. Thanks to @psufka for organizing and it was nice to meet the man behind the legend! @Drbeckyg @maio_danila https://t.co/lSpPz0V4ng
Juan Ovalles, MD, PhD DrJuanOvalles
2 years 2 months ago
Therapeutic approach to skin in #Scleroderma
#ACR19 https://t.co/ZV8J5Z0wum
Jose Campos JoseCamposMD
2 years 2 months ago
Couldn’t be explained better https://t.co/m7qmeWCLnl
Kanika Monga, MD DrKanikaMonga
2 years 2 months ago
Myositis Treatment Pearls
- Optimize drug dose and allow adequate time to reach effectiveness
- Steroids NOT always necessary
- Steroids and IVIG are the fastest acting agents
- Reasons for admission: dysphagia and SOB
Dr. Paul Sufka psufka
2 years 2 months ago
Primary care providers - take a look at these new gout guidelines. They're very straightforward, and your patients will do much better than if you follow the ACP guidelines. #ACR19 https://t.co/BIGLj6GKRe
Laurent ARNAUD Lupusreference
2 years 2 months ago
Hello #ACR19. Are you still confused 😲 about the #pathways of #JAK-inhibitors and #Interferon-blocking strategies in #Lupus? Check up this refresher slide showing what these #SLE #treatments target!! 🎯 https://t.co/ZNnJTkz4nK
Cassandra Calabrese CCalabreseDO
2 years 2 months ago
That’s a wrap on #ACR2019 ! Check out @RheumNow for meeting coverage, and see you next year in DC! @LCalabreseDO #cleclinicrheum https://t.co/sx2M5sD6pU
Janet Pope Janetbirdope
2 years 2 months ago
Never thought I'd say it. ACR in beautiful Atlanta. Kind of grows on you. #ACR #ACR19 @RheumNow https://t.co/YJOi5lEQei
Dr. Paul Sufka psufka
2 years 2 months ago
My post on @RheumNow: “Muscle loss and frailty in rheumatic disease" https://t.co/lpTBAPkrbV #ACR19
Jonathan Hausmann MD hausmannMD
2 years 2 months ago
The most interesting disease topic of #ACR19? Systemic JIA-associated lung disease. An increasingly recognized complication of #SJIA with poor prognosis.https://t.co/ySHLbU5Pjc@RheumNow
Dr. Rachel Tate uptoTate
2 years 2 months ago
Asymptomatic sacroiliitis was observed in about 15% of young IBD pts. Entero MRI may be helpful for early inflammatory changes in IBD pts. abst #1174 #ACR19 @RheumNow https://t.co/sQxj8cmuKd
Janet Pope Janetbirdope
2 years 2 months ago
Thanks. I forgot about low all phosph as a tip off for hypophosphatemia. Results in CPPD, calcific tendonitis and osteoporosis #ACR @RheumNow https://t.co/RkoeRAXggt
